Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia

Sponsor
University of Miami (Other)
Overall Status
Recruiting
CT.gov ID
NCT05055336
Collaborator
American Neurogastroenterology and Motility Society (Other)
90
1
3
11
8.2

Study Details

Study Description

Brief Summary

The purpose of this research is to further study the relationship between gastroparesis (GP) (a condition in which the stomach cannot empty itself of food in a normal fashion) and functional dyspepsia (FD) (frequent symptoms of indigestion that have no obvious cause).

Condition or Disease Intervention/Treatment Phase
  • Other: Gastric emptying breath test
  • Other: Stomach ultrasound
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia: Toward Individualized Care in Functional Abdominal Pain Disorders
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gastroparesis

Participants in this group are children diagnosed with gastroparesis per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.

Other: Gastric emptying breath test
The gastric emptying breath test is used to diagnose gastroparesis. Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.

Other: Stomach ultrasound
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.

Experimental: Dyspepsia

Participants in this group are children diagnosed with functional dyspepsia per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.

Other: Gastric emptying breath test
The gastric emptying breath test is used to diagnose gastroparesis. Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.

Other: Stomach ultrasound
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.

Experimental: Healthy Controls

Participants in this group are children that do not have gastroparesis, functional dyspepsia, or any other gastroenterology condition. Participants will be getting an ultrasound once.

Other: Stomach ultrasound
Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.

Outcome Measures

Primary Outcome Measures

  1. Gastric emptying rate [up to 6 months]

    As measured by the spirulina breath test

Secondary Outcome Measures

  1. Percentage of food retained in the stomach [Day 1]

    Fundic accommodation will be reported as the percentage of food retained in the fundus using an ultrasound before and after meal ingestion.

  2. Pediatric Cardinal Symptoms Questionnaire Scores [Up to 6 months]

    The pediatric symptoms questionnaires has a total score ranging from 0-600. Higher score means worse symptoms.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Able to complete the Pediatric Cardinal Symptoms Questionnaire

  • Both parent and child must be able to speak and understand English or Spanish

Exclusion Criteria:
  • Have global developmental delay, autism disorder, or psychosis

  • Are nonverbal and/or illiterate

  • Lack fluency in English or Spanish

  • Have other GI comorbidities such as inflammatory bowel disease, celiac disease, eosinophilic esophagitis, peptic ulcer disease, GI malignancy, or gastroesophageal reflux disease responsive to medications (medical records will be reviewed to detect these exclusions)

  • Have a history of surgical procedures that could have potentially affected their GI tract anatomy, such as fundoplication or Ladd's procedure.

  • Healthy child presenting to their well child care visit must not report a history of dyspepsia, have a history of any gastrointestinal disease, or be taking any medication that can disturb the GI tract motility.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Miami Miami Florida United States 33136

Sponsors and Collaborators

  • University of Miami
  • American Neurogastroenterology and Motility Society

Investigators

  • Principal Investigator: Liz Febo-Rodriguez, MD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Liz Febo-Rodriguez, Assistant Professor, University of Miami
ClinicalTrials.gov Identifier:
NCT05055336
Other Study ID Numbers:
  • 20210662
First Posted:
Sep 24, 2021
Last Update Posted:
Apr 28, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 28, 2022